Safety of in vitro amplified HLA-haploidentical donor immune cell infusions for childhood malignancies

Safety of in vitro amplified HLA-haploidentical donor immune cell infusions for childhood malignancies

In vitro amplified human leukocyte antigen (HLA)-haploidentical donor immune cell infusion (HDICI) is not commonly used in children. Therefore, our study sought to evaluate its safety for treating childhood malignancies. Between September 2011 and September 2012, 12 patients with childhood malignanc...

Full description

Bibliographic Details
Main Authors: Zhang, Fei, Sun, Xiao-Fei, Li, Yong-Qiang, Zhen, Zi-Jun, Zheng, Hai-Xia, Zhu, Jia, Wang, Qi-Jing, Lu, Su-Ying, He, Jia, Wang, Juan, Pan, Ke, Cai, Rui-Qing, Chen, Yan, Weng, De-Sheng, Sun, Fei-Fei, Xia, Jian-Chuan
Format: Online
Language:English
Published: Sun Yat-sen University Cancer Center 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870850/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870850/

Similar Items